Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
AbCellera Biologics Inc.
IPO Date: December 11, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.18B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.39 | 3.08%
Avg Daily Range (30 D): $0.19 | 5.21%
Avg Daily Range (90 D): $0.11 | 3.96%
Institutional Daily Volume
Avg Daily Volume: 2.14M
Avg Daily Volume (30 D): 7.83M
Avg Daily Volume (90 D): 5.23M
Trade Size
Avg Trade Size (Sh.): 156
Avg Trade Size (Sh.) (30 D): 297
Avg Trade Size (Sh.) (90 D): 330
Institutional Trades
Total Inst.Trades: 1,174
Avg Inst. Trade: $1.88M
Avg Inst. Trade (30 D): $.81M
Avg Inst. Trade (90 D): $1.13M
Avg Inst. Trade Volume: .16M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.09M
Avg Closing Trade (30 D): $.83M
Avg Closing Trade (90 D): $.79M
Avg Closing Volume: 203.03K
   
News
Jun 13, 2024 @ 9:40 AM
Down 57%, Is AbCellera Biologics a Buy on the Dip?...
Source: newsfeedback@fool.com (Cory Renauer)
May 8, 2024 @ 8:30 AM
AbCellera Biologics (ABCL) Q1 2024 Earnings Call T...
Source: newsfeedback@fool.com (Motley Fool Transcribing)
May 7, 2024 @ 10:05 PM
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, M...
Source: Zacks Equity Research
May 1, 2024 @ 2:01 PM
Cytokinetics (CYTK) May Report Negative Earnings: ...
Source: Zacks Equity Research
Apr 30, 2024 @ 2:01 PM
Analysts Estimate AbCellera Biologics Inc. (ABCL) ...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-.15 $-.17
Diluted EPS $-.15 $-.17
Revenue $ $ 4.24M $ 6.51M
Gross Profit $ $ $
Net Income / Loss $ $ -45.62M $ -51.11M
Operating Income / Loss $ $ -62.66M $ -93.66M
Cost of Revenue $ $ $
Net Cash Flow $ $ 2.94M $ -21.67M
PE Ratio